AVANOS MEDICAL, INC. 8-K

What Happened Avanos Medical, Inc. (AVNS) filed a Form 8-K on January 13, 2026 to disclose, under Item 7.01 (Regulation FD Disclosure), that it will present and discuss a slide presentation at the JP Morgan Healthcare Conference. The presentation is furnished as Exhibit 99.1 to the Current Report and is dated January 13, 2026. The report was signed by John J. Hurley, Controller.

Key Details

• Filing date: January 13, 2026 (Form 8-K).
• Item reported: 7.01 Regulation FD Disclosure — slide presentation to be presented at the JP Morgan Healthcare Conference.
• Exhibit included: Exhibit 99.1 — Presentation dated January 13, 2026.
• No other items (e.g., earnings, executive changes, mergers) were reported in this 8-K.

Why It Matters This filing publicly distributes the company’s conference presentation under Regulation FD so all investors have simultaneous access to the same information management will discuss at a major industry event. While the 8-K itself does not report earnings, revenue, or management changes, the slides may contain strategic updates, product or pipeline information, and forward-looking commentary that could influence investor perceptions. Investors should review Exhibit 99.1 (the attached presentation) for details and monitor any subsequent disclosures or Q&A from the conference.